Faculty

Institution

Unit

Venue

Robert N. Pechnick

Western University of Health Sciences

Affiliations

College Of Osteopathic Medicine Of The Pacific

School Of Osteopathic Medicine Of The Pacific Northwest

Western University of Health Sciences

NoneRobert N. Pechnick is currently serving as a College Of Osteopathic Medicine Of The Pacific faculty at Western University of Health Sciences.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Robert N. Pechnick

Western University of Health Sciences

You can click a keyword to filter the displayed items

neuroscience psychiatry pharmacology neuropharmacology neuropsychopharmacology psychopharmacology psychiatric research psychotropic medication systematic review neurology molecular neuroscience translational psychiatry gene therapy psychoneuroendocrinology biological psychiatry brain tumor research behavioral neuroscience pharmacotherapy molecular neurodegeneration medicinal research molecular psychiatry psychiatric care brain-immune interaction inflammation neuroimmunology toxicology oncology experimental medicine addiction biology applied pharmacology neuroinflammation nicotine behavioural pharmacology cancer treatment neurochemistry neuroprotection viral oncology clinical neuroscience psychiatric disorders clinical psychiatry hypothalamo-pituitary-adrenal axis safety profile approved psychiatric medications cellular physiology behavioural process adrenal glands neuroendocrine mechanisms glucocorticoids neural stem cells stress hormones subgranular zone nicotine-seeking behavior forced swim test leukemia inhibitory factor psychoneuroimmunology chronic inflammation brain function homeostatic mechanisms allostatic load sensorimotor transformations pituitary disease cellular neurobiology structural plasticity molecular neurobiology apoptosis relapse prevention behavioral addictions clinical therapeutics oligomeric ab behavioral impairment tau pathology chronic peripheral inflammation neuronal proliferation dentate gyrus p21 expression neuronal progenitors

Notable Scholarly Works

Notable Federal Grants

Collaborators

Neurocognitive Disorders: Systematic Review of Approved (2008-2024) and Pipeline Phase III Medications.. PubMed (2026)

neurologysystematic reviewclinical neurologyneuroscienceneuropsychological rehabilitationcognitive impairmenttranslational psychiatryneuropsychiatryclinical neuroscienceneurocognitive disordersneuropsychologyattention disorders

Anxiety Disorders, Ptsd and Ocd: Systematic Review of Approved Psychiatric Medications (2008–2024) and Pipeline Phase III Medications. Drugs in Context (2025)

mental healthpsychiatric caresystematic reviewpsychiatrypsychotropic medicationapproved psychiatric medicationsclinical psychiatrytranslational psychiatrymedicinepsychopathologypsychiatric researchanxiety disorderspsychology

Bipolar Disorder: Systematic Review of Approved Psychiatric Medications (2008–2024) and Pipeline Phase-3 Medications. Journal of Affective Disorders (2025)

psychiatric diseasessystematic reviewpsychiatrypsychotropic medicationpsychiatric disordersbipolar disorderapproved psychiatric medicationstranslational psychiatrymedicinepsychopathologypsychiatric researchpsychiatric epidemiology

Depressive Disorders: Systematic Review of Approved Psychiatric Medications (2009-April 2025) and Pipeline Phase 3 Medications. BMC Psychiatry (2025)

mental healthpsychiatric caresystematic reviewpsychiatrymood symptomdepressive disorderspsychotropic medicationpsychiatric disorderstranslational psychiatrypipeline phase 3therapeutic approachesmedicineaffective disorderspsychiatric researchdepression

Schizophrenia Management: Systematic Review of Current Medications and Phase-3 Agents (2008–2024). Neuroscience Applied (2025)

Salma AbdelmotelebJayant TotlaniSalma RamadanMohamed SalemAshley MeyerTiffany ChangMadeline EwingLuiza FreireNathalie MurphySabrina RenteriaRomana DymkoskiOmer LiranRebecca HedrickItai DanovitchRobert N. PechnickWaguih William IsHak

schizophrenia managementneuropharmacologybiological psychiatryschizophrenianeurosciencepharmacologypsychopharmacologypsychiatric researchpsychiatric caresystematic reviewclinical psychiatrycurrent medicationsclinical neurosciencemental healthpsychotropic medicationneuropsychopharmacologytranslational psychiatrypsychopathologypsychiatrypsychotic disordersclinical research

Sleep-Wake Disorders. Journal of Clinical Psychopharmacology (2025)

Antigen-Specific Age-Related Memory Cd8 T Cells Induce and Track Alzheimer’s-Like Neurodegeneration. Proceedings of the National Academy of Sciences (2024)

Akanksha PanwarAltan RentsendorjMichelle JhunRobert M. CohenRyan CordnerNicole GullRobert N. PechnickGretchen DuvallArmen MardirosDavid GolchianHannah SchubloomLee-Way JinDebby Van DamYannick VermeirenHans De ReuPeter Paul De DeynJevgenij A. RaskatovKeith L. BlackDwain K. IrvinBrian A. WilliamsChristopher J. Wheeler

alzheimer's diseasememorycell signalingimmunologycell biologyneuroscienceimmune responsescellular immune responsesadaptive immune systembrain-immune interactionantigen processingimmunological memorygene expression

Overview of Approved Psychiatric Medications 2008-2023: A Systematic Review. World Journal of Advanced Research and Reviews (2024)

None Waguih William IsHakNone Jayant TotlaniNone Nathalie MurphyNone Sabrina RenteriaNone Tiffany ChangNone Rasha AbdelsalamNone Mohamed SalemNone Ashley MeyerNone Rida KhanNone Thomas ChandyNone Emile TadrosNone Drew HirschNone Robert A. ChernoffNone Sarah KimNone Scott IrwinNone Rebecca HedrickNone Itai DanovitchNone Robert N. Pechnick

mental healthpsychiatric caresystematic reviewpsychiatrypsychotropic medicationapproved psychiatric medicationsclinical psychiatrypsychiatric evaluationspharmacologyclinical researchpsychiatric researchpsychopathologypsychiatric epidemiologyclinical psychology

Overview of Psychiatric Medications in the Pipeline in Phase III Trials as of June 1, 2024: A Systematic Review.. PubMed (2024)

Waguih William IsHakAshley MeyerLuiza FreireJayant TotlaniNathalie MurphySabrina RenteriaMohamed SalemTiffany ChangRasha AbdelsalamRida KhanThomas ChandyThomas ParrishDrew HirschBhumika PatelAlexander J SteinerSarah KimRebecca HedrickRobert N PechnickItai Danovitch

systematic reviewpsychiatryphase iii trialsdrug trialspsychiatric medicationspsychiatric researchclinical trials

Systematic Review of Long-Acting Injectable Antipsychotic Medications Approved From 2008 to October 2024 and Agents in Phase 3. The International Journal of Psychiatry in Medicine (2024)

systematic reviewpsychiatryindividualized medicinepsychotropic medicationapplied pharmacologyphase 3medicinepharmacologypsychopharmacologypharmacotherapypsychiatric researchclinical trials

1
2
3
4
5
10 / page

Robert N. Pechnick

Western University of Health Sciences

Affiliations

College Of Osteopathic Medicine Of The Pacific

School Of Osteopathic Medicine Of The Pacific Northwest

Western University of Health Sciences

NoneRobert N. Pechnick is currently serving as a College Of Osteopathic Medicine Of The Pacific faculty at Western University of Health Sciences.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Robert N. Pechnick

Western University of Health Sciences

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Neurocognitive Disorders: Systematic Review of Approved (2008-2024) and Pipeline Phase III Medications.. PubMed (2026)

Anxiety Disorders, Ptsd and Ocd: Systematic Review of Approved Psychiatric Medications (2008–2024) and Pipeline Phase III Medications. Drugs in Context (2025)

Bipolar Disorder: Systematic Review of Approved Psychiatric Medications (2008–2024) and Pipeline Phase-3 Medications. Journal of Affective Disorders (2025)

Depressive Disorders: Systematic Review of Approved Psychiatric Medications (2009-April 2025) and Pipeline Phase 3 Medications. BMC Psychiatry (2025)

Schizophrenia Management: Systematic Review of Current Medications and Phase-3 Agents (2008–2024). Neuroscience Applied (2025)

Sleep-Wake Disorders. Journal of Clinical Psychopharmacology (2025)

Antigen-Specific Age-Related Memory Cd8 T Cells Induce and Track Alzheimer’s-Like Neurodegeneration. Proceedings of the National Academy of Sciences (2024)

Overview of Approved Psychiatric Medications 2008-2023: A Systematic Review. World Journal of Advanced Research and Reviews (2024)

Overview of Psychiatric Medications in the Pipeline in Phase III Trials as of June 1, 2024: A Systematic Review.. PubMed (2024)

systematic reviewpsychiatryphase iii trialsdrug trialspsychiatric medicationspsychiatric researchclinical trials

Systematic Review of Long-Acting Injectable Antipsychotic Medications Approved From 2008 to October 2024 and Agents in Phase 3. The International Journal of Psychiatry in Medicine (2024)

systematic reviewpsychiatryindividualized medicinepsychotropic medicationapplied pharmacologyphase 3medicinepharmacologypsychopharmacologypharmacotherapypsychiatric researchclinical trials

1
2
3
4
5
10 / page